PlumX Metrics
Embed PlumX Metrics

Implementing low-cost, community-based exercise programs for middle-aged and older patients with type 2 diabetes: What are the benefits for glycemic control and cardiovascular risk?

International Journal of Environmental Research and Public Health, ISSN: 1660-4601, Vol: 14, Issue: 9
2017
  • 25
    Citations
  • 0
    Usage
  • 180
    Captures
  • 1
    Mentions
  • 28
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    25
  • Captures
    180
  • Mentions
    1
    • Blog Mentions
      1
      • Blog
        1
  • Social Media
    28
    • Shares, Likes & Comments
      28
      • Facebook
        28

Article Description

Background: The purpose of this study was to analyze the effects of a long-term, community-based, combined exercise program developed with low-cost exercise strategies on glycemic control and cardiovascular risk factors in middle-aged and older patients with type 2 diabetes. Methods: Participants (n = 124; 63.25 ± 7.20 years old) engaged in either a 9-month supervised exercise program (n = 39; consisting of combined aerobic, resistance, agility/balance, and flexibility exercise; three sessions per week; 70 min per session) or a control group (n = 85) who maintained their usual care. Glycemic control, lipid profile, blood pressure, anthropometric profile, and the 10-year risk of coronary artery disease were assessed before and after the 9-month intervention. Results: A significant time * group interaction effect (p < 0.001) was identified in the values of the glycated hemoglobin, fasting plasma glucose, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, systolic blood pressure, diastolic blood pressure, body mass index, waist circumference, and the 10-year risk of coronary artery disease. Conclusions: A long-term, community-based, combined exercise program developed with low-cost exercise strategies was effective in inducing significant benefits on glycemic control, lipid profile, blood pressure, anthropometric profile, and the 10-year risk of coronary artery disease in middle-aged and older patients with type 2 diabetes. Clinical Trial Identification Number: ISRCTN09240628.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know